本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

5.25
-0.0500-0.94%
盘后5.250.00000.00%16:37 EDT
成交量:5.60万
成交额:29.77万
市值:3,210.01万
市盈率:-0.25
高:5.55
开:5.24
低:5.17
收:5.30
数据加载中...
2021/05/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/27

重要事件披露

8-K - Current report
2021/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/23

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/25

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/30

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/20

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/20

重要事件披露

8-K - Current report
2020/10/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933